drugset / Trial / NCT00348010

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee

NCT00348010

Phase 3 Completed 245 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the analgesic effectiveness and safety of tramadol HCl ER to placebo in patients with moderate to severe pain due to osteoarthritis (OA). The study hypothesis is that tramadol HCl ER is effective and safe in the treatment of OA.

Timeline

Start
2000-11
Primary completion
Completion
2001-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 200 mg

Indications